Small Molecules

Sitting Down With... Sauri Gudlavalleti, Global Head of Integrated Product Development Organization (IPDO), Dr. Reddy’s Laboratories.

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.

Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.

Sitting Down With… Tom Moody, VP of Technology Development and Commercialization at Almac, Craigavon, UK.

We speak with Nik Kotecha, CEO of Morningside, to discuss why pharma companies have a responsibility to take the lead in helping others.

How will the coronavirus impact manufacturing supply chains?

Eliminating infectious diseases that lead to blindness in Africa – an eye-opening view from the frontlines featuring Sightsavers.

The small molecule drug development pipeline is booming! And it means new opportunities for CDMOs.

The best machinery can only be made with the input of the people who use it everyday.

Could fluorescent silk proteins be the answer to the pharmaceutical industry's fake drug problem?